164 related articles for article (PubMed ID: 19414111)
41. Activating transcription factor 2 increases transactivation and protein stability of hypoxia-inducible factor 1alpha in hepatocytes.
Choi JH; Cho HK; Choi YH; Cheong J
Biochem J; 2009 Nov; 424(2):285-96. PubMed ID: 19712049
[TBL] [Abstract][Full Text] [Related]
42. The role of hypoxia-inducible transcription factors in the hypoxic neonatal brain.
Trollmann R; Gassmann M
Brain Dev; 2009 Aug; 31(7):503-9. PubMed ID: 19398180
[TBL] [Abstract][Full Text] [Related]
43. The HIF1alpha-inducible pro-cell death gene BNIP3 is a novel target of SIM2s repression through cross-talk on the hypoxia response element.
Farrall AL; Whitelaw ML
Oncogene; 2009 Oct; 28(41):3671-80. PubMed ID: 19668230
[TBL] [Abstract][Full Text] [Related]
44. Sphingosine-1-phosphate: a novel nonhypoxic activator of hypoxia-inducible factor-1 in vascular cells.
Michaud MD; Robitaille GA; Gratton JP; Richard DE
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):902-8. PubMed ID: 19423865
[TBL] [Abstract][Full Text] [Related]
45. Selective killing of hypoxia-inducible factor-1-active cells improves survival in a mouse model of invasive and metastatic pancreatic cancer.
Kizaka-Kondoh S; Itasaka S; Zeng L; Tanaka S; Zhao T; Takahashi Y; Shibuya K; Hirota K; Semenza GL; Hiraoka M
Clin Cancer Res; 2009 May; 15(10):3433-41. PubMed ID: 19417024
[TBL] [Abstract][Full Text] [Related]
46. Regulation of vascularization by hypoxia-inducible factor 1.
Semenza GL
Ann N Y Acad Sci; 2009 Oct; 1177():2-8. PubMed ID: 19845601
[TBL] [Abstract][Full Text] [Related]
47. [Recent progress in the study on antitumor drugs targeting hypoxia-inducible factor-1].
Wang JJ; Li J; Geng MY
Yao Xue Xue Bao; 2008 Jun; 43(6):565-9. PubMed ID: 18822956
[TBL] [Abstract][Full Text] [Related]
48. The human oxygen sensing machinery and its manipulation.
Chowdhury R; Hardy A; Schofield CJ
Chem Soc Rev; 2008 Jul; 37(7):1308-19. PubMed ID: 18568157
[TBL] [Abstract][Full Text] [Related]
49. Regulation of angiogenesis by hypoxia and hypoxia-inducible factors.
Hickey MM; Simon MC
Curr Top Dev Biol; 2006; 76():217-57. PubMed ID: 17118268
[TBL] [Abstract][Full Text] [Related]
50. Molecular genetics of hereditary renal cancer: new genes and diagnostic and therapeutic opportunities.
Hansel DE; Rini BI
Expert Rev Anticancer Ther; 2008 Jun; 8(6):895-905. PubMed ID: 18533799
[TBL] [Abstract][Full Text] [Related]
51. STAT1 represses hypoxia-inducible factor-1-mediated transcription.
Hiroi M; Mori K; Sakaeda Y; Shimada J; Ohmori Y
Biochem Biophys Res Commun; 2009 Oct; 387(4):806-10. PubMed ID: 19646959
[TBL] [Abstract][Full Text] [Related]
52. Metastatic renal cell carcinoma: many treatment options, one patient.
Rini BI
J Clin Oncol; 2009 Jul; 27(19):3225-34. PubMed ID: 19470934
[TBL] [Abstract][Full Text] [Related]
53. Molecular imaging: into in vivo interaction of HIF-1alpha and HIF-2alpha with ARNT.
Konietzny R; König A; Wotzlaw C; Bernadini A; Berchner-Pfannschmidt U; Fandrey J
Ann N Y Acad Sci; 2009 Oct; 1177():74-81. PubMed ID: 19845609
[TBL] [Abstract][Full Text] [Related]
54. Hypoxia-inducible factor 1 as a possible target for cancer chemoprevention.
López-Lázaro M
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2332-5. PubMed ID: 17164353
[TBL] [Abstract][Full Text] [Related]
55. Interrelationships among hypoxia-inducible factor biology and acid-base equilibrium.
Hulter HN; Krapf R
Semin Nephrol; 2006 Nov; 26(6):454-65. PubMed ID: 17275583
[TBL] [Abstract][Full Text] [Related]
56. Renal cell carcinoma.
Garcia JA; Cowey CL; Godley PA
Curr Opin Oncol; 2009 May; 21(3):266-71. PubMed ID: 19339887
[TBL] [Abstract][Full Text] [Related]
57. Belzutifan: First Approval.
Deeks ED
Drugs; 2021 Nov; 81(16):1921-1927. PubMed ID: 34613603
[TBL] [Abstract][Full Text] [Related]
58. Targeted therapy for advanced renal cell cancer: cytokines and beyond.
Papaetis GS; Karapanagiotou LM; Pandha H; Syrigos KN
Curr Pharm Des; 2008; 14(22):2229-51. PubMed ID: 18781974
[TBL] [Abstract][Full Text] [Related]
59. The HIF pathway in cancer.
Maxwell PH
Semin Cell Dev Biol; 2005; 16(4-5):523-30. PubMed ID: 16144689
[TBL] [Abstract][Full Text] [Related]
60. The interplay between MYC and HIF in cancer.
Dang CV; Kim JW; Gao P; Yustein J
Nat Rev Cancer; 2008 Jan; 8(1):51-6. PubMed ID: 18046334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
